Smiths Group PLC
20 March 2006
PRESS RELEASE
IMMEDIATE RELEASE Monday 20 March 2006
Smiths Medical announces intention to end manufacturing in Hythe
Smiths Medical has announced its intention to transfer 534 manufacturing jobs
from its facility in Hythe, Kent. The majority of the proposed job transfers
will move to existing Smiths Medical manufacturing facilities in Mexico.
Proposals were put to the workforce today that are likely to see manufacturing
at Hythe end within two years.
The company has, however, reaffirmed the role of Hythe as the headquarters of
Smiths Medical International and as its centre of excellence for airway
management and reproductive health products. These activities are expected to
employ around 220 people engaged in R&D, finance, marketing and other support
services. Hythe will also see the creation of a new European shared service
centre.
This announcement marks the next important step in Smiths Medical's
rationalisation programme that follows its acquisition of Medex in March 2005.
Over the past two months the company also announced the closure of two US
manufacturing facilities in Duluth, Georgia and Wampsville, New York with
production transferring to other Smiths Medical locations in the US.
Martin Jamieson, Managing Director Smiths Medical International said: 'This move
is driven by the global competitive environment for our business. Our
competitors have all made similar moves to low-cost countries, which makes
today's announcement unavoidable. We are sorry that this will affect many of our
employees and their families but pleased that Hythe will still offer employment
to more than two hundred people in some key functions. We will, with immediate
effect, commence a consultation and communication process with employees and
their representatives '
Notes to the Editor
Smiths Group
Smiths Group is a global business, listed on the London Stock Exchange. Smiths
focuses on high performance applications, building and sustaining market-leading
businesses in growth sectors. Smiths has four divisions: Aerospace, Detection,
Medical and Specialty. Together these employ 32,000 people at over 250 major
facilities in 50 countries. For more information visit www.smiths-group.com
Smiths Medical
Smiths Medical is a supplier of specialist medical devices to global markets.
Smiths Medical comprises three product groupings: Safety Devices, Critical Care
and Medication Delivery & Patient Monitoring (MDPM). Smiths Medical customers
include hospitals and other healthcare providers worldwide. Manufacturing is
concentrated in the US, the UK, Mexico and Italy. Smiths Medical employs nearly
7,500 people.
Press Contacts
Chris Fox Rachel Lankester
Director, Group Communications Manager, Group Communications
+44 (0) 20 8457 8403 +44 (0) 20 8457 8403
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.